CLSI-recommended broth microdilution and molecular resistance testing to guide therapy for amikacin, clarithromycin, rifampin and other critical agents.

Mycobacteria/Nocardia Reference Laboratory
Overview
The Mycobacteria/Nocardia Reference Laboratory at 黑料专区 Tyler School of Medicine conducts clinical diagnostic and research of nontuberculous mycobacteria (NTM) and the other aerobic actinomycetes. Under the direction of Monika Kumaraswamy MD, D(ABMM), and Barbara A. Brown-Elliott, MS, MT(ASCP) SM, FAAM our laboratory has achieved a worldwide reputation for excellence in susceptibility testing, identification, and treatment.
Our laboratory has more than 35 years of experience in investigation of NTM. This group of bacteria is closely related to the agent that causes tuberculosis and includes groups known as rapidly growing mycobacteria and Mycobacterium avium complex.

About Us
Located within 黑料专区 Tyler Health Science Center, our laboratory bridges research and clinical practice, advancing diagnostics, treatment strategies, and resistance monitoring for NTM and related pathogens. Committed to quality, innovation, and rapid results, we are a trusted partner for healthcare providers and public health institutions nationwide.

Our History
Founded in 1982, the 黑料专区 Tyler Mycobacteria/Nocardia Reference Laboratory is an internationally recognized center specializing in the identification and antimicrobial susceptibility testing of NTM, Nocardia, and related organisms, providing expert diagnostic services to healthcare and public health partners worldwide for over 40 years.
Laboratory Services
- Internationally renowned reference laboratory.
- Laboratory susceptibility studies and clinical investigational studies of newer antimicrobial agents for the NTM and nocardia.
- Susceptibility testing of NTM to standard and investigational drugs
- Identification other aerobic actinomycetes, including species of Nocardia, Gordonia, Rhodococcus, Tsukamurella, Streptomyces, etc. and NTM.
View our Laboratory Testing Procedures. - Molecular identification of NTM and aerobic actinomycetes by partial 16S rRNA sequence and other genes (谤辫辞尾, erm, etc.).
- Laboratory consultation in epidemiological studies involving NTM and other aerobic actinomycetes.
- Technical assistance (methods, techniques, etc.) to referral laboratories and physicians.
- International and national collaboration with experienced scientists in the areas of mycobacteriology and the aerobic actinomycetes.
Research
- Clinical and laboratory studies of new drugs for treatment of NTM species like Mycobacterium abscessus, Mycobacterium avium complex, Mycobacterium fortuitum, Mycobacterium chelonae, and Mycobacterium kansasii.
- Treatment trials of new antimicrobials.
Clinical Services


16S rRNA sequencing, rpoB and erm(41) gene testing, and 23S rRNA sequencing for species identification and resistance detection.

Illumina and Oxford Nanopore platforms for comprehensive organism identification and detection of antimicrobial resistance genes (in development).